SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

BIOYF (BIOYF)

BIOYF RSS Feed
Add BIOYF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/19/2015 3:04:59 AM - Followers: 14 - Board type: Free - Posts Today: 0


BioSyent is a profitable, growth oriented specialty pharmaceutical company that sources and markets innovative products. The company acquires the exclusive rights to patented pharmaceutical products that have already been proven to be safe and effective, and then markets and distributes them in Canada. The company focuses on products with small but very profitable addressable markets ($2-15 million peak penetration) in Canada. The company's goal is to acquire and distribute two to four new products per year, thus showing consistent profitable growth.



Total sales for Q2 2014 of $3,072,395, were 72% higher compared to $1,786,684 in the corresponding prior year period. Total Sales for H1 2014 of $5,520,496 were 66% higher than H1 2013.

Pharmaceutical Sales in Q2 2014 increased by 72% from $1,683,793 in Q2 2013 to $2,893,162 in Q2 2014. Total Pharmaceutical Sales for H1 2014 of $5,236,170 were 75% higher than H1 2013.

Net Income Before Tax for Q2 2014 was $1,219,855, which was 125% higher than $542,964 in Q2 2013. Net Income Before Tax for H1 2014 was $1,907,527 or 86% higher than the corresponding prior year period.

Net Income After Tax increased by 112% from $418,325 in Q2 2013 to $888,805 in Q2 2014. Net Income After Tax for H1 2014 was $1,400,226 or 84% higher than the corresponding prior year period.

  The company remains debt-free and has an unutilized operating line of credit with Royal Bank of Canada    




BIOYF Security Details
Share Structure
Market Value $115,710,000 a/o Aug 27, 2014
Shares Outstanding 13,800,000 a/o Jun 30, 2014
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BIOYF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BIOYF News: Venue Change 05/15/2013 03:01:03 PM
PostSubject
#18   BioSyent Releases Results for Third Quarter and First Trent Blair 11/19/15 03:04:59 AM
#17   BIOYF - BioSyent Releases First Six Months 2015 JustGoLong 08/12/15 10:01:36 AM
#16   Anyone still here? ronpopeil 05/27/15 04:18:59 PM
#15   http://finance.yahoo.com/news/biosyent-releases-q4-full-2014-130000405.html Nice Trent Blair 04/12/15 04:33:51 AM
#14   Earnings will send BIOYF to $15 by year's end HallaDurg 10/09/14 11:40:58 AM
#13   Stocktrademan Thanx 4 info Great Post Balystyk 09/11/14 04:12:07 PM
#12   $BIOYF DD Notes ~ http://www.ddnotesmaker.com/BIOYF stocktrademan 09/11/14 03:13:51 PM
#11   Crushing through $10 JamieFlagg 09/11/14 02:27:43 PM
#10   I can't say I mind the daily 1-2% JamieFlagg 09/10/14 07:53:47 PM
#9   Will really fly with increased investor awareness Balystyk 09/10/14 07:40:23 PM
#8   It's pretty boring talking to myself on this JamieFlagg 09/09/14 11:33:58 PM
#7   Been following this company for some time now. JamieFlagg 09/04/14 10:44:45 PM
#6   Closing out at 9.26 this stock posts gains JamieFlagg 09/03/14 04:08:11 PM
#5   $9.19 new lifetime high!!! JamieFlagg 09/03/14 11:27:08 AM
#4   $9 - New 52 week high! BIOYF is HallaDurg 09/03/14 09:58:25 AM
#3   This stock was sent by the gods!! JamieFlagg 09/02/14 11:26:57 AM
#2   2014 Q2 Financials: HallaDurg 08/28/14 11:25:26 AM
#1   BioSyent Releases Q2 and Six Month Results-Q2 Sales HallaDurg 08/28/14 11:22:00 AM
PostSubject